| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2007;84:17-24
© 2007 The Society of Thoracic Surgeons
a Department of Thoracic and Cardiovascular Surgery, West-German Heart Center Essen, Essen, Germany
b Institute for Medical Informatics, Biometry, and Epidemiology, University Hospital Essen, Essen, Germany
Accepted for publication March 27, 2007.
* Address correspondence to Dr Thielmann, Department of Thoracic and Cardiovascular Surgery, West-German Heart Center, University Hospital Essen Hufelandstraße 55, Essen, 45122, Germany (Email: matthias.thielmann{at}uni-due.de).
Presented at the Poster Session of the Forty-third Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Jan 29–31, 2007.
Background: Treatment of ST-elevation myocardial infarction has undergone great evolution since introduction of percutaneous coronary intervention (PCI). The purpose was therefore to assess the outcome of patients with ST-elevation myocardial infarction undergoing surgical revascularization with coronary artery bypass grafting (CABG).
Methods: A total of 138 consecutive patients with ST-elevation myocardial infarction underwent CABG therapy between January 2000 and January 2007 at our institution. Prospectively recorded preoperative, intraoperative, and postoperative data were retrospectively screened for in-hospital mortality and major adverse cardiac events (MACE).
Results: The delay between the onset of ST-elevation myocardial infarction symptoms and CABG procedures was within 6 hours in 37 patients, 7 to 24 hours in 21, 1 to 3 days in 15, 4 to 7 days in 24, and 8 to 14 days in 41 patients. Cardiogenic shock (Killip class 
III) was present in 38 patients (28%), and 37 patients (27%) were referred for CABG after failed PCI. Overall in-hospital mortality was 8.7%, but mortality varied between 10.8% (
6 hours), 23.8% (7 to 24 hours), 6.7% (1 to 3 days), 4.2% (4 to 7 days), and 2.4% (8 to 14 days), depending on time interval from symptom onset to operation. Overall, more nonsurvivors were women (58% versus 23%; p < 0.01), had higher preoperative cardiac troponin I levels (13.2 ± 9.8 versus 4.5 ± 4.2 ng/ml; p < 0.0001), and were more frequently in cardiogenic shock (83% versus 22%; p < 0.0001). Unadjusted univariable and risk-adjusted multivariable logistic regression analysis revealed age, female sex, preoperative cardiac troponin I levels, and cardiogenic shock to be the most potent predictors of in-hospital death and MACE.
Conclusions: CABG in ST-elevation myocardial infarction can be performed with acceptable risk by incorporating adequate management strategies. However, female sex, preoperative cardiac troponin I level, preoperative cardiogenic shock, and time to operation are major variables of mortality and morbidity results.
Related Article
Ann. Thorac. Surg. 2007 84: 24.
This article has been cited by other articles:
|
|
 |
|
  R. J. Morris Invited commentary. Ann. Thorac. Surg., December 1, 2009; 88(6): 1792 - 1792. [Full Text] [PDF]
|
|
|
|
|
|
B. C. Danner, V. N. Didilis, T. Stojanovic, A. Popov, M. Grossmann, R. Seipelt, and F. A. Schondube A three-group model to predict mortality in emergent coronary artery bypass graft surgery. Ann. Thorac. Surg., November 1, 2009; 88(5): 1433 - 1439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Knosalla Invited commentary Ann. Thorac. Surg., July 1, 2007; 84(1): 24 - 24. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
